Cite
Feasibility of percutaneous epicardial mapping and ablation for refractory atrial fibrillation: Insights into substrate and lesion transmurality.
MLA
Jiang, Ruhong, et al. “Feasibility of Percutaneous Epicardial Mapping and Ablation for Refractory Atrial Fibrillation: Insights into Substrate and Lesion Transmurality.” Heart Rhythm, vol. 16, no. 8, Aug. 2019, pp. 1151–59. EBSCOhost, https://doi.org/10.1016/j.hrthm.2019.02.018.
APA
Jiang, R., Buch, E., Gima, J., Upadhyay, G. A., Nayak, H. M., Beaser, A. D., Aziz, Z., Shivkumar, K., & Tung, R. (2019). Feasibility of percutaneous epicardial mapping and ablation for refractory atrial fibrillation: Insights into substrate and lesion transmurality. Heart Rhythm, 16(8), 1151–1159. https://doi.org/10.1016/j.hrthm.2019.02.018
Chicago
Jiang, Ruhong, Eric Buch, Jean Gima, Gaurav A Upadhyay, Hemal M Nayak, Andrew D Beaser, Zaid Aziz, Kalyanam Shivkumar, and Roderick Tung. 2019. “Feasibility of Percutaneous Epicardial Mapping and Ablation for Refractory Atrial Fibrillation: Insights into Substrate and Lesion Transmurality.” Heart Rhythm 16 (8): 1151–59. doi:10.1016/j.hrthm.2019.02.018.